269 related articles for article (PubMed ID: 21566665)
1. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
[TBL] [Abstract][Full Text] [Related]
2. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
3. A20: a jack of all trades.
Hertens P; van Loo G
Trends Cell Biol; 2024 May; 34(5):360-362. PubMed ID: 38461099
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.
Devos M; Mogilenko DA; Fleury S; Gilbert B; Becquart C; Quemener S; Dehondt H; Tougaard P; Staels B; Bachert C; Vandenabeele P; Van Loo G; Staumont-Salle D; Declercq W; Dombrowicz D
J Invest Dermatol; 2019 Jan; 139(1):135-145. PubMed ID: 30118730
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth.
Schmidt-Ullrich R; Tobin DJ; Lenhard D; Schneider P; Paus R; Scheidereit C
Development; 2006 Mar; 133(6):1045-57. PubMed ID: 16481354
[TBL] [Abstract][Full Text] [Related]
6. Identification of dkk4 as a target of Eda-A1/Edar pathway reveals an unexpected role of ectodysplasin as inhibitor of Wnt signalling in ectodermal placodes.
Fliniaux I; Mikkola ML; Lefebvre S; Thesleff I
Dev Biol; 2008 Aug; 320(1):60-71. PubMed ID: 18508042
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
8. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
De A; Dainichi T; Rathinam CV; Ghosh S
EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
[TBL] [Abstract][Full Text] [Related]
10. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
11. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
12. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
Enesa K; Moll HP; Luong L; Ferran C; Evans PC
FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
[TBL] [Abstract][Full Text] [Related]
13. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
Shembade N; Ma A; Harhaj EW
Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
[TBL] [Abstract][Full Text] [Related]
15. Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development.
Pispa J; Pummila M; Barker PA; Thesleff I; Mikkola ML
Hum Mol Genet; 2008 Nov; 17(21):3380-91. PubMed ID: 18689798
[TBL] [Abstract][Full Text] [Related]
16. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
17. A20 and CYLD do not share significant overlapping functions during B cell development and activation.
Chu Y; Soberon V; Glockner L; Beyaert R; Massoumi R; van Loo G; Krappmann D; Schmidt-Supprian M
J Immunol; 2012 Nov; 189(9):4437-43. PubMed ID: 23002441
[TBL] [Abstract][Full Text] [Related]
18. Identification of ectodysplasin target genes reveals the involvement of chemokines in hair development.
Lefebvre S; Fliniaux I; Schneider P; Mikkola ML
J Invest Dermatol; 2012 Apr; 132(4):1094-102. PubMed ID: 22277947
[TBL] [Abstract][Full Text] [Related]
19. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.
Matmati M; Jacques P; Maelfait J; Verheugen E; Kool M; Sze M; Geboes L; Louagie E; Mc Guire C; Vereecke L; Chu Y; Boon L; Staelens S; Matthys P; Lambrecht BN; Schmidt-Supprian M; Pasparakis M; Elewaut D; Beyaert R; van Loo G
Nat Genet; 2011 Aug; 43(9):908-12. PubMed ID: 21841782
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
